Ventyx Biosciences Ownership | Who Owns Ventyx Biosciences?
Ventyx Biosciences Ownership Summary
Ventyx Biosciences is owned by 11.44% institutional investors, 4.13% insiders, and 84.43% retail investors. Blackrock is the largest institutional shareholder, holding 7.72% of VTYX shares. American Funds SMALLCAP World A is the top mutual fund, with 7.43% of its assets in Ventyx Biosciences shares.
VTYX Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Ventyx Biosciences | 11.44% | 4.13% | 84.43% |
Sector | Healthcare Stocks | 279.19% | 10.62% | -189.81% |
Industry | Biotech Stocks | 63.96% | 10.74% | 25.30% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Blackrock | 4.77M | 7.72% | $11.02M |
Blackrock funding, inc. /de | 4.50M | 6.37% | $9.86M |
Ubs group | 3.78M | 5.35% | $8.28M |
Vanguard group | 3.51M | 4.96% | $7.68M |
Tang capital management | 3.10M | 4.39% | $6.79M |
Sio capital management | 2.58M | 3.63% | $2.97M |
Vestal point capital, lp | 2.00M | 2.81% | $2.30M |
Point72 asset management | 1.78M | 2.52% | $3.90M |
Redmile group | 1.57M | 2.21% | $1.81M |
Goldman sachs group | 1.51M | 2.14% | $3.31M |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Qiming u.s. ventures management | 412.23K | 1.77% | $902.77K |
Sio capital management | 2.58M | 0.88% | $2.97M |
Tang capital management | 3.10M | 0.45% | $6.79M |
Sphera funds management | 1.01M | 0.40% | $2.22M |
Ikarian capital | 1.22M | 0.17% | $1.40M |
Redmile group | 1.57M | 0.17% | $1.81M |
Vestal point capital, lp | 2.00M | 0.16% | $2.30M |
Wexford capital lp | 398.46K | 0.14% | $872.63K |
Monaco asset management sam | 240.00K | 0.08% | $525.60K |
Tcg crossover management | 316.19K | 0.07% | $692.47K |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Ubs group | 3.78M | 0.00% | 2.59M |
Point72 asset management | 1.78M | 0.01% | 1.78M |
Redmile group | 1.57M | 0.17% | 1.45M |
Blackrock | 4.77M | 0.00% | 1.02M |
Jacobs levy equity management | 475.73K | 0.00% | 475.73K |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Capital investors | - | - | -5.25M |
Farallon capital management | - | - | -3.17M |
Cormorant asset management, lp | - | - | -2.71M |
Octagon capital advisors lp | - | - | -2.39M |
Orbimed advisors | - | - | -1.87M |
New Positions
Holder | Shares | % Assets | Change | Value |
---|---|---|---|---|
Point72 asset management | 1.78M | 0.01% | 1.78M | $3.90M |
Jacobs levy equity management | 475.73K | 0.00% | 475.73K | $1.10M |
Monaco asset management sam | 240.00K | 0.08% | 240.00K | $525.60K |
Susquehanna fundamental investments | 198.95K | 0.01% | 198.95K | $435.69K |
Bnp paribas arbitrage, snc | 126.14K | 0.00% | 126.14K | $276.25K |
Sold Out
Holder | Change |
---|---|
Nelson, van denburg & campbell wealth management group | -9.00 |
Zurcher kantonalbank (zurich cantonalbank) | -55.00 |
Avion wealth | -63.00 |
Federation des caisses desjardins du quebec | -120.00 |
Modus advisors | -150.00 |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Mar 31, 2025 | 9 | -92.91% | 8,136,748 | -85.06% | 11 | 0.19% | 4 | -94.20% | 3 | -89.66% |
Dec 31, 2024 | 121 | 1.68% | 53,151,208 | 1.28% | 75 | 1.36% | 65 | 8.33% | 28 | -9.68% |
Sep 30, 2024 | 119 | - | 52,481,496 | -7.84% | 74 | 1.14% | 60 | 7.14% | 31 | -16.22% |
Jun 30, 2024 | 118 | -9.23% | 56,948,301 | -3.20% | 92 | 0.93% | 56 | -26.32% | 36 | -5.26% |
Mar 31, 2024 | 130 | 4.00% | 58,833,410 | 36.04% | 99 | 1.85% | 76 | - | 38 | 15.15% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
American Funds SMALLCAP World A | 5.25M | 7.43% | 2.89M |
Vanguard Total Stock Mkt Idx Inv | 1.78M | 2.50% | - |
iShares Russell 2000 ETF | 1.55M | 2.18% | 759.00 |
Vanguard Institutional Extnd Mkt Idx Tr | 873.00K | 1.23% | - |
Fidelity Small Cap Index | 619.86K | 0.87% | - |
iShares Russell 2000 Value ETF | 538.02K | 0.76% | - |
Delaware Healthcare I | 430.00K | 0.61% | - |
Macquarie Healthcare I | 430.00K | 0.60% | - |
State St Russell Sm/Mid Cp® Indx NL Cl C | 419.68K | 0.59% | - |
State St Russell Sm/Mid Cp® Indx SL Cl I | 419.68K | 0.59% | - |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Apr 02, 2025 | Nuss John | CHIEF SCIENTIFIC OFFICER | Sell | $2.02K |
Dec 27, 2024 | Nuss John | CHIEF SCIENTIFIC OFFICER | Sell | $49.84K |
Dec 23, 2024 | Gujrathi Sheila | - | Buy | $300.57K |
Dec 19, 2024 | Nuss John | CHIEF SCIENTIFIC OFFICER | Sell | $29.68K |
Nov 25, 2024 | Mohan Raju | CEO AND PRESIDENT | Buy | $524.94K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2025 Q2 | - | 1 |
2025 Q1 | - | - |
2024 Q4 | 3 | 2 |
2024 Q3 | - | - |
2024 Q2 | - | 4 |
VTYX Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools